Skip to main content

Table 2 Methodological quality of the randomized controlled trials

From: The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up

Study

Random sequence generation

Allocation concealment

Blinding of participates and personal

Blinding of outcome assessment

Incomplete outcome data

Selective reporting

Other bias

Kinov, 2005

Low risk

Low risk

Unclear risk

Unclear risk

Low risk

Low risk

Unclear

Yamasaki, 2006

Low risk

Low risk

Unclear risk

Unclear risk

Low risk

Low risk

Unclear

Skoldenberg, 2011

Low risk

Low risk

Low risk

Unclear risk

Low risk

Low risk

Unclear

Muren, 2015

Low risk

Low risk

Low risk

Unclear risk

Low risk

Low risk

Unclear